Award recordCONTRACT

GENZYME CORPORATION

PIID VA24412J0230· VHA· 642-PHILADELPHIA· Q523 · MEDICAL- SURGERY· FY2012· $266,294 net obligations· UEI X2XMAQLR9DA8· MA

Description

OTHER FUNCTIONS - SPECIALIZED ANATOMIS PATHOLOGY TESTING

Base award description: SPECIALIZED ANATOMIS PATHOLOGY TESTING

First action · last action
2011-12-14 · 2013-01-15
Transactions
3
First transaction's obligation
$180,000
Base + all options value (sum of deltas)
$266,294
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
Parent IDV
V797P5702X
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 3 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$279,999$0Base award · 2011-12-14 · this action $180,000 · running total $180,000Modification P0001 · 2012-08-10 · this action $99,999 · running total $279,999Modification P00002 · 2013-01-15 · this action -$13,705 · running total $266,294
  • Base2011-12-14+$180,000= $180,000
  • Mod P00012012-08-10+$99,999= $279,999
  • Mod P000022013-01-15-$13,705= $266,294
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2011-12-14+$180,000$180,000SPECIALIZED ANATOMIS PATHOLOGY TESTING
Mod P0001· OTHER ADMINISTRATIVE ACTION2012-08-10+$99,999$279,999OTHER FUNCTIONS - SPECIALIZED ANATOMIS PATHOLOGY TESTING
Mod P00002· OTHER ADMINISTRATIVE ACTION2013-01-15−$13,705$266,294OTHER FUNCTIONS - SPECIALIZED ANATOMIS PATHOLOGY TESTING

Related awards · 8

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI X2XMAQLR9DA8)

AwardOffice · PSC / listingNet obligationsFY
36E79724A0018NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS$0FY2024
36C26124N0260261-NETWORK CONTRACT OFFICE 21 (36C261) · 6505 · DRUGS AND BIOLOGICALS$11,882FY2024
36C26023F0186260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$144,553FY2023
36C26223F0045262-NETWORK CONTRACT OFFICE 22 (36C262) · 6505 · DRUGS AND BIOLOGICALS$246,001FY2023
36C26223F0022262-NETWORK CONTRACT OFFICE 22 (36C262) · 6505 · DRUGS AND BIOLOGICALS$266,652FY2023
36C26222F0606262-NETWORK CONTRACT OFFICE 22 (36C262) · 6505 · DRUGS AND BIOLOGICALS$20,049FY2022

Other recipients under Q523 from 642-PHILADELPHIA (most recent first)

AwardRecipientOfficeNet obligationsFY
VA24414P0454INTEGRA LIFESCIENCES CORPORATION642-PHILADELPHIA$7,830FY2014
VA24413P2562INTEGRA LIFESCIENCES CORPORATION642-PHILADELPHIA$11,745FY2013

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA24412J0230_3600_V797P5702X_3600 · retrieved 2026-09-26.